TI
IGMS

Trexquant Investment’s IGM Biosciences IGMS Stock Holding History

Trexquant Investment’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,177
Closed -$233K – 1671
2024
Q1 		$233K Buy
+24,177
New +$280K ﹤0.01% 1341
2023
Q3 		– Sell
-23,387
Closed -$216K – 1622
2023
Q2 		$216K Buy
+23,387
New +$262K 0.01% 1294
2021
Q4 		– Sell
-3,380
Closed -$222K – 1439
2021
Q3 		$222K Buy
+3,380
New +$259K 0.02% 904

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Trexquant Investment's IGMS Position: Q2 2024 in Review

Trexquant Investment sold out of IGM Biosciences (IGMS) in Q2 2024, closing a stake of 24,177 shares — an estimated $233K sold.

Trexquant Investment first reported a position in IGMS in Q3 2021 and held it in 3 quarters. The position peaked at $233K in Q1 2024. 82 funds tracked by Wall St. Rank hold IGMS as of Q2 2024.

  • Trexquant Investment reported no remaining IGM Biosciences position as of Q2 2024 after selling out during the quarter.
  • Trexquant Investment sold 24,177 IGM Biosciences shares in Q2 2024, an estimated $233K.
  • Trexquant Investment first reported a position in IGM Biosciences in Q3 2021 and held it in 3 quarters.
  • Trexquant Investment's IGM Biosciences position peaked at $233K in Q1 2024.
  • 82 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.